Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia


Sevinc A., ÖZKAN M., Ozet A., DANE F., Oksuzoglu B., Isikdogan A., et al.

ONCOTARGETS AND THERAPY, cilt.11, ss.419-426, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 11
  • Basım Tarihi: 2018
  • Doi Numarası: 10.2147/ott.s106342
  • Dergi Adı: ONCOTARGETS AND THERAPY
  • Sayfa Sayısı: ss.419-426

Özet

Background: We studied the comparative effectiveness of biosimilar filgrastim vs original filgrastim in patients with chemotherapy-induced neutropenia.